Global Precision Cancer Diagnostic Tests Market Research Report 2024
Number of Pages: 173
Category: Medical Devices & Consumables
Country: Tibet
Format:
Published Date: 10 Jan 2024
Report Overview:
Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.
The Global Precision Cancer Diagnostic Tests Market Size was estimated at USD 4829.57 million in 2023 and is projected to reach USD 9790.92 million by 2029, exhibiting a CAGR of 12.50% during the forecast period.
This report provides a deep insight into the global Precision Cancer Diagnostic Tests market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Precision Cancer Diagnostic Tests Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Precision Cancer Diagnostic Tests market in any manner.
Global Precision Cancer Diagnostic Tests Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Market Segmentation (by Type)
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Precision Cancer Diagnostic Tests Market
• Overview of the regional outlook of the Precision Cancer Diagnostic Tests Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.
The Global Precision Cancer Diagnostic Tests Market Size was estimated at USD 4829.57 million in 2023 and is projected to reach USD 9790.92 million by 2029, exhibiting a CAGR of 12.50% during the forecast period.
This report provides a deep insight into the global Precision Cancer Diagnostic Tests market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Precision Cancer Diagnostic Tests Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Precision Cancer Diagnostic Tests market in any manner.
Global Precision Cancer Diagnostic Tests Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Market Segmentation (by Type)
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Precision Cancer Diagnostic Tests Market
• Overview of the regional outlook of the Precision Cancer Diagnostic Tests Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Precision Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Diagnostic Tests Segment by Type
1.2.2 Precision Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Precision Cancer Diagnostic Tests Market Overview
2.1 Global Market Overview
2.1.1 Global Precision Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Precision Cancer Diagnostic Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Precision Cancer Diagnostic Tests Market Competitive Landscape
3.1 Global Precision Cancer Diagnostic Tests Sales by Manufacturers (2019-2024)
3.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Precision Cancer Diagnostic Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Precision Cancer Diagnostic Tests Sales Sites, Area Served, Product Type
3.6 Precision Cancer Diagnostic Tests Market Competitive Situation and Trends
3.6.1 Precision Cancer Diagnostic Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Precision Cancer Diagnostic Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.1 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Precision Cancer Diagnostic Tests Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Precision Cancer Diagnostic Tests Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
6.3 Global Precision Cancer Diagnostic Tests Market Size Market Share by Type (2019-2024)
6.4 Global Precision Cancer Diagnostic Tests Price by Type (2019-2024)
7 Precision Cancer Diagnostic Tests Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Diagnostic Tests Market Sales by Application (2019-2024)
7.3 Global Precision Cancer Diagnostic Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
8 Precision Cancer Diagnostic Tests Market Segmentation by Region
8.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Precision Cancer Diagnostic Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Precision Cancer Diagnostic Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Precision Cancer Diagnostic Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Precision Cancer Diagnostic Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Precision Cancer Diagnostic Tests Basic Information
9.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
9.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Precision Cancer Diagnostic Tests SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Agilent Technologies
9.2.1 Agilent Technologies Precision Cancer Diagnostic Tests Basic Information
9.2.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
9.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.2.4 Agilent Technologies Business Overview
9.2.5 Agilent Technologies Precision Cancer Diagnostic Tests SWOT Analysis
9.2.6 Agilent Technologies Recent Developments
9.3 Becton Dickinson and Company
9.3.1 Becton Dickinson and Company Precision Cancer Diagnostic Tests Basic Information
9.3.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
9.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Market Performance
9.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests SWOT Analysis
9.3.5 Becton Dickinson and Company Business Overview
9.3.6 Becton Dickinson and Company Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Basic Information
9.4.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
9.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.4.4 Bio-Rad Laboratories Business Overview
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Biocartis N.V.
9.5.1 Biocartis N.V. Precision Cancer Diagnostic Tests Basic Information
9.5.2 Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
9.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.5.4 Biocartis N.V. Business Overview
9.5.5 Biocartis N.V. Recent Developments
9.6 Biocept
9.6.1 Biocept Precision Cancer Diagnostic Tests Basic Information
9.6.2 Biocept Precision Cancer Diagnostic Tests Product Overview
9.6.3 Biocept Precision Cancer Diagnostic Tests Product Market Performance
9.6.4 Biocept Business Overview
9.6.5 Biocept Recent Developments
9.7 bioMerieux SA
9.7.1 bioMerieux SA Precision Cancer Diagnostic Tests Basic Information
9.7.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
9.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Product Market Performance
9.7.4 bioMerieux SA Business Overview
9.7.5 bioMerieux SA Recent Developments
9.8 Canon Medical Systems Corporation
9.8.1 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Basic Information
9.8.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
9.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.8.4 Canon Medical Systems Corporation Business Overview
9.8.5 Canon Medical Systems Corporation Recent Developments
9.9 Cynvenio Biosystems
9.9.1 Cynvenio Biosystems Precision Cancer Diagnostic Tests Basic Information
9.9.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
9.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Market Performance
9.9.4 Cynvenio Biosystems Business Overview
9.9.5 Cynvenio Biosystems Recent Developments
9.10 Danaher Corporation
9.10.1 Danaher Corporation Precision Cancer Diagnostic Tests Basic Information
9.10.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
9.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.10.4 Danaher Corporation Business Overview
9.10.5 Danaher Corporation Recent Developments
9.11 Epigenomics AG
9.11.1 Epigenomics AG Precision Cancer Diagnostic Tests Basic Information
9.11.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
9.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Product Market Performance
9.11.4 Epigenomics AG Business Overview
9.11.5 Epigenomics AG Recent Developments
9.12 Exosome Diagnostics
9.12.1 Exosome Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.12.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.12.4 Exosome Diagnostics Business Overview
9.12.5 Exosome Diagnostics Recent Developments
9.13 Foundation Medicine
9.13.1 Foundation Medicine Precision Cancer Diagnostic Tests Basic Information
9.13.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
9.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Product Market Performance
9.13.4 Foundation Medicine Business Overview
9.13.5 Foundation Medicine Recent Developments
9.14 General Electric Company
9.14.1 General Electric Company Precision Cancer Diagnostic Tests Basic Information
9.14.2 General Electric Company Precision Cancer Diagnostic Tests Product Overview
9.14.3 General Electric Company Precision Cancer Diagnostic Tests Product Market Performance
9.14.4 General Electric Company Business Overview
9.14.5 General Electric Company Recent Developments
9.15 Genomic Health
9.15.1 Genomic Health Precision Cancer Diagnostic Tests Basic Information
9.15.2 Genomic Health Precision Cancer Diagnostic Tests Product Overview
9.15.3 Genomic Health Precision Cancer Diagnostic Tests Product Market Performance
9.15.4 Genomic Health Business Overview
9.15.5 Genomic Health Recent Developments
9.16 Hologic
9.16.1 Hologic Precision Cancer Diagnostic Tests Basic Information
9.16.2 Hologic Precision Cancer Diagnostic Tests Product Overview
9.16.3 Hologic Precision Cancer Diagnostic Tests Product Market Performance
9.16.4 Hologic Business Overview
9.16.5 Hologic Recent Developments
9.17 Illumina
9.17.1 Illumina Precision Cancer Diagnostic Tests Basic Information
9.17.2 Illumina Precision Cancer Diagnostic Tests Product Overview
9.17.3 Illumina Precision Cancer Diagnostic Tests Product Market Performance
9.17.4 Illumina Business Overview
9.17.5 Illumina Recent Developments
9.18 Menarini Silicon Biosystems SpA
9.18.1 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Basic Information
9.18.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
9.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Market Performance
9.18.4 Menarini Silicon Biosystems SpA Business Overview
9.18.5 Menarini Silicon Biosystems SpA Recent Developments
9.19 Myriad Genetics
9.19.1 Myriad Genetics Precision Cancer Diagnostic Tests Basic Information
9.19.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
9.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Product Market Performance
9.19.4 Myriad Genetics Business Overview
9.19.5 Myriad Genetics Recent Developments
9.20 NanoString Technologies
9.20.1 NanoString Technologies Precision Cancer Diagnostic Tests Basic Information
9.20.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
9.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.20.4 NanoString Technologies Business Overview
9.20.5 NanoString Technologies Recent Developments
9.21 Ortho Clinical Diagnostics
9.21.1 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.21.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.21.4 Ortho Clinical Diagnostics Business Overview
9.21.5 Ortho Clinical Diagnostics Recent Developments
9.22 QIAGEN N.V.
9.22.1 QIAGEN N.V. Precision Cancer Diagnostic Tests Basic Information
9.22.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
9.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.22.4 QIAGEN N.V. Business Overview
9.22.5 QIAGEN N.V. Recent Developments
9.23 Randox Laboratories Ltd.
9.23.1 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Basic Information
9.23.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
9.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Market Performance
9.23.4 Randox Laboratories Ltd. Business Overview
9.23.5 Randox Laboratories Ltd. Recent Developments
9.24 Roche Holding AG
9.24.1 Roche Holding AG Precision Cancer Diagnostic Tests Basic Information
9.24.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
9.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Product Market Performance
9.24.4 Roche Holding AG Business Overview
9.24.5 Roche Holding AG Recent Developments
9.25 Royal Philips N.V.
9.25.1 Royal Philips N.V. Precision Cancer Diagnostic Tests Basic Information
9.25.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
9.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.25.4 Royal Philips N.V. Business Overview
9.25.5 Royal Philips N.V. Recent Developments
9.26 Siemens AG
9.26.1 Siemens AG Precision Cancer Diagnostic Tests Basic Information
9.26.2 Siemens AG Precision Cancer Diagnostic Tests Product Overview
9.26.3 Siemens AG Precision Cancer Diagnostic Tests Product Market Performance
9.26.4 Siemens AG Business Overview
9.26.5 Siemens AG Recent Developments
9.27 Thermo Fisher Scientific
9.27.1 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Basic Information
9.27.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
9.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Market Performance
9.27.4 Thermo Fisher Scientific Business Overview
9.27.5 Thermo Fisher Scientific Recent Developments
9.28 Vela Diagnostics
9.28.1 Vela Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.28.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.28.4 Vela Diagnostics Business Overview
9.28.5 Vela Diagnostics Recent Developments
10 Precision Cancer Diagnostic Tests Market Forecast by Region
10.1 Global Precision Cancer Diagnostic Tests Market Size Forecast
10.2 Global Precision Cancer Diagnostic Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.3 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region
10.2.4 South America Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Precision Cancer Diagnostic Tests by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Precision Cancer Diagnostic Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.1.2 Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.2 Global Precision Cancer Diagnostic Tests Market Forecast by Application (2025-2030)
11.2.1 Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application
11.2.2 Global Precision Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Precision Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Diagnostic Tests Segment by Type
1.2.2 Precision Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Precision Cancer Diagnostic Tests Market Overview
2.1 Global Market Overview
2.1.1 Global Precision Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Precision Cancer Diagnostic Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Precision Cancer Diagnostic Tests Market Competitive Landscape
3.1 Global Precision Cancer Diagnostic Tests Sales by Manufacturers (2019-2024)
3.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Precision Cancer Diagnostic Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Precision Cancer Diagnostic Tests Sales Sites, Area Served, Product Type
3.6 Precision Cancer Diagnostic Tests Market Competitive Situation and Trends
3.6.1 Precision Cancer Diagnostic Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Precision Cancer Diagnostic Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.1 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Precision Cancer Diagnostic Tests Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Precision Cancer Diagnostic Tests Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
6.3 Global Precision Cancer Diagnostic Tests Market Size Market Share by Type (2019-2024)
6.4 Global Precision Cancer Diagnostic Tests Price by Type (2019-2024)
7 Precision Cancer Diagnostic Tests Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Diagnostic Tests Market Sales by Application (2019-2024)
7.3 Global Precision Cancer Diagnostic Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
8 Precision Cancer Diagnostic Tests Market Segmentation by Region
8.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Precision Cancer Diagnostic Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Precision Cancer Diagnostic Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Precision Cancer Diagnostic Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Precision Cancer Diagnostic Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Precision Cancer Diagnostic Tests Basic Information
9.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
9.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Precision Cancer Diagnostic Tests SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Agilent Technologies
9.2.1 Agilent Technologies Precision Cancer Diagnostic Tests Basic Information
9.2.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
9.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.2.4 Agilent Technologies Business Overview
9.2.5 Agilent Technologies Precision Cancer Diagnostic Tests SWOT Analysis
9.2.6 Agilent Technologies Recent Developments
9.3 Becton Dickinson and Company
9.3.1 Becton Dickinson and Company Precision Cancer Diagnostic Tests Basic Information
9.3.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
9.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Market Performance
9.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests SWOT Analysis
9.3.5 Becton Dickinson and Company Business Overview
9.3.6 Becton Dickinson and Company Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Basic Information
9.4.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
9.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.4.4 Bio-Rad Laboratories Business Overview
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Biocartis N.V.
9.5.1 Biocartis N.V. Precision Cancer Diagnostic Tests Basic Information
9.5.2 Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
9.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.5.4 Biocartis N.V. Business Overview
9.5.5 Biocartis N.V. Recent Developments
9.6 Biocept
9.6.1 Biocept Precision Cancer Diagnostic Tests Basic Information
9.6.2 Biocept Precision Cancer Diagnostic Tests Product Overview
9.6.3 Biocept Precision Cancer Diagnostic Tests Product Market Performance
9.6.4 Biocept Business Overview
9.6.5 Biocept Recent Developments
9.7 bioMerieux SA
9.7.1 bioMerieux SA Precision Cancer Diagnostic Tests Basic Information
9.7.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
9.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Product Market Performance
9.7.4 bioMerieux SA Business Overview
9.7.5 bioMerieux SA Recent Developments
9.8 Canon Medical Systems Corporation
9.8.1 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Basic Information
9.8.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
9.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.8.4 Canon Medical Systems Corporation Business Overview
9.8.5 Canon Medical Systems Corporation Recent Developments
9.9 Cynvenio Biosystems
9.9.1 Cynvenio Biosystems Precision Cancer Diagnostic Tests Basic Information
9.9.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
9.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Market Performance
9.9.4 Cynvenio Biosystems Business Overview
9.9.5 Cynvenio Biosystems Recent Developments
9.10 Danaher Corporation
9.10.1 Danaher Corporation Precision Cancer Diagnostic Tests Basic Information
9.10.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
9.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.10.4 Danaher Corporation Business Overview
9.10.5 Danaher Corporation Recent Developments
9.11 Epigenomics AG
9.11.1 Epigenomics AG Precision Cancer Diagnostic Tests Basic Information
9.11.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
9.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Product Market Performance
9.11.4 Epigenomics AG Business Overview
9.11.5 Epigenomics AG Recent Developments
9.12 Exosome Diagnostics
9.12.1 Exosome Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.12.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.12.4 Exosome Diagnostics Business Overview
9.12.5 Exosome Diagnostics Recent Developments
9.13 Foundation Medicine
9.13.1 Foundation Medicine Precision Cancer Diagnostic Tests Basic Information
9.13.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
9.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Product Market Performance
9.13.4 Foundation Medicine Business Overview
9.13.5 Foundation Medicine Recent Developments
9.14 General Electric Company
9.14.1 General Electric Company Precision Cancer Diagnostic Tests Basic Information
9.14.2 General Electric Company Precision Cancer Diagnostic Tests Product Overview
9.14.3 General Electric Company Precision Cancer Diagnostic Tests Product Market Performance
9.14.4 General Electric Company Business Overview
9.14.5 General Electric Company Recent Developments
9.15 Genomic Health
9.15.1 Genomic Health Precision Cancer Diagnostic Tests Basic Information
9.15.2 Genomic Health Precision Cancer Diagnostic Tests Product Overview
9.15.3 Genomic Health Precision Cancer Diagnostic Tests Product Market Performance
9.15.4 Genomic Health Business Overview
9.15.5 Genomic Health Recent Developments
9.16 Hologic
9.16.1 Hologic Precision Cancer Diagnostic Tests Basic Information
9.16.2 Hologic Precision Cancer Diagnostic Tests Product Overview
9.16.3 Hologic Precision Cancer Diagnostic Tests Product Market Performance
9.16.4 Hologic Business Overview
9.16.5 Hologic Recent Developments
9.17 Illumina
9.17.1 Illumina Precision Cancer Diagnostic Tests Basic Information
9.17.2 Illumina Precision Cancer Diagnostic Tests Product Overview
9.17.3 Illumina Precision Cancer Diagnostic Tests Product Market Performance
9.17.4 Illumina Business Overview
9.17.5 Illumina Recent Developments
9.18 Menarini Silicon Biosystems SpA
9.18.1 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Basic Information
9.18.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
9.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Market Performance
9.18.4 Menarini Silicon Biosystems SpA Business Overview
9.18.5 Menarini Silicon Biosystems SpA Recent Developments
9.19 Myriad Genetics
9.19.1 Myriad Genetics Precision Cancer Diagnostic Tests Basic Information
9.19.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
9.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Product Market Performance
9.19.4 Myriad Genetics Business Overview
9.19.5 Myriad Genetics Recent Developments
9.20 NanoString Technologies
9.20.1 NanoString Technologies Precision Cancer Diagnostic Tests Basic Information
9.20.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
9.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.20.4 NanoString Technologies Business Overview
9.20.5 NanoString Technologies Recent Developments
9.21 Ortho Clinical Diagnostics
9.21.1 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.21.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.21.4 Ortho Clinical Diagnostics Business Overview
9.21.5 Ortho Clinical Diagnostics Recent Developments
9.22 QIAGEN N.V.
9.22.1 QIAGEN N.V. Precision Cancer Diagnostic Tests Basic Information
9.22.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
9.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.22.4 QIAGEN N.V. Business Overview
9.22.5 QIAGEN N.V. Recent Developments
9.23 Randox Laboratories Ltd.
9.23.1 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Basic Information
9.23.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
9.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Market Performance
9.23.4 Randox Laboratories Ltd. Business Overview
9.23.5 Randox Laboratories Ltd. Recent Developments
9.24 Roche Holding AG
9.24.1 Roche Holding AG Precision Cancer Diagnostic Tests Basic Information
9.24.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
9.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Product Market Performance
9.24.4 Roche Holding AG Business Overview
9.24.5 Roche Holding AG Recent Developments
9.25 Royal Philips N.V.
9.25.1 Royal Philips N.V. Precision Cancer Diagnostic Tests Basic Information
9.25.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
9.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.25.4 Royal Philips N.V. Business Overview
9.25.5 Royal Philips N.V. Recent Developments
9.26 Siemens AG
9.26.1 Siemens AG Precision Cancer Diagnostic Tests Basic Information
9.26.2 Siemens AG Precision Cancer Diagnostic Tests Product Overview
9.26.3 Siemens AG Precision Cancer Diagnostic Tests Product Market Performance
9.26.4 Siemens AG Business Overview
9.26.5 Siemens AG Recent Developments
9.27 Thermo Fisher Scientific
9.27.1 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Basic Information
9.27.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
9.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Market Performance
9.27.4 Thermo Fisher Scientific Business Overview
9.27.5 Thermo Fisher Scientific Recent Developments
9.28 Vela Diagnostics
9.28.1 Vela Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.28.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.28.4 Vela Diagnostics Business Overview
9.28.5 Vela Diagnostics Recent Developments
10 Precision Cancer Diagnostic Tests Market Forecast by Region
10.1 Global Precision Cancer Diagnostic Tests Market Size Forecast
10.2 Global Precision Cancer Diagnostic Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.3 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region
10.2.4 South America Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Precision Cancer Diagnostic Tests by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Precision Cancer Diagnostic Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.1.2 Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.2 Global Precision Cancer Diagnostic Tests Market Forecast by Application (2025-2030)
11.2.1 Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application
11.2.2 Global Precision Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings